These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36502788)

  • 1. L-Theanine alleviates MPTP-induced Parkinson's disease by targeting Wnt/β-catenin signaling mediated by the MAPK signaling pathway.
    Ratih K; Lee YR; Chung KH; Song DH; Lee KJ; Kim DH; An JH
    Int J Biol Macromol; 2023 Jan; 226():90-101. PubMed ID: 36502788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.
    Zhao Y; Zhang Q; Xi J; Xiao B; Li Y; Ma C
    Int J Clin Exp Pathol; 2015; 8(3):2354-64. PubMed ID: 26045742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.
    Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY
    Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mangiferin alleviates 6-OHDA-induced Parkinson's disease by inhibiting AKR1C3 to activate Wnt signaling pathway.
    Huang W; Wang Y; Huang W
    Neurosci Lett; 2024 Jan; 821():137608. PubMed ID: 38142926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of ginsenoside Rg1 through the Wnt/β-catenin signaling pathway in both in vivo and in vitro models of Parkinson's disease.
    Zhou T; Zu G; Zhang X; Wang X; Li S; Gong X; Liang Z; Zhao J
    Neuropharmacology; 2016 Feb; 101():480-9. PubMed ID: 26525190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
    Pariyar R; Bastola T; Lee DH; Seo J
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
    Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
    Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of fermented tea in MPTP-induced Parkinson's disease mouse model via MAPK signaling-mediated regulation of inflammation and antioxidant activity.
    Lee YR; Moon GH; Shim D; Kim JC; Lee KJ; Chung KH; An JH
    Food Res Int; 2023 Feb; 164():112133. PubMed ID: 36737888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-theanine attenuates LPS-induced motor deficit in experimental rat model of Parkinson's disease: emphasis on mitochondrial activity, neuroinflammation, and neurotransmitters.
    Kumar S; Awasthi A; Raj K; Singh S
    Psychopharmacology (Berl); 2023 Jul; 240(7):1493-1508. PubMed ID: 37191688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. l-theanine, the unique constituent of tea, improves neuronal survivability by curtailing inflammatory responses in MPTP model of Parkinson's disease.
    Deb S; Borah A
    Neurochem Int; 2024 Oct; 179():105830. PubMed ID: 39128625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt/β-catenin signaling is required to rescue midbrain dopaminergic progenitors and promote neurorepair in ageing mouse model of Parkinson's disease.
    L'Episcopo F; Tirolo C; Testa N; Caniglia S; Morale MC; Serapide MF; Pluchino S; Marchetti B
    Stem Cells; 2014 Aug; 32(8):2147-63. PubMed ID: 24648001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Neuroprotective Effects of GPR4 Inhibition through the Attenuation of Caspase Mediated Apoptotic Cell Death in an MPTP Induced Mouse Model of Parkinson's Disease.
    Haque ME; Azam S; Akther M; Cho DY; Kim IS; Choi DK
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the TLR/NF-
    Su Y; Li M; Wang Q; Xu X; Qin P; Huang H; Zhang Y; Zhou Y; Yan J
    Oxid Med Cell Longev; 2022; 2022():1837278. PubMed ID: 36589679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meloxicam ameliorates motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling in a mouse Parkinson's disease model.
    Tasaki Y; Yamamoto J; Omura T; Sakaguchi T; Kimura N; Ohtaki K; Ono T; Suno M; Asari M; Ohkubo T; Noda T; Awaya T; Shimizu K; Matsubara K
    Neurosci Lett; 2012 Jul; 521(1):15-9. PubMed ID: 22617635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
    Li H; Park G; Bae N; Kim J; Oh MS; Yang HO
    J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress.
    Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ
    Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Wnt/β-catenin signaling attenuates axonal degeneration in models of Parkinson's disease.
    Huang YL; Zhang JN; Hou TZ; Gu L; Yang HM; Zhang H
    Neurochem Int; 2022 Oct; 159():105389. PubMed ID: 35809720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vinpocetine improves dyskinesia in Parkinson's disease rats by reducing oxidative stress and activating the Wnt/β-catenin signaling pathway.
    Ji M; Niu SQ; Mi HY; Jiang P; Li Y
    Chem Biol Drug Des; 2024 Jan; 103(1):e14358. PubMed ID: 37749299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective Effect of Coptis chinensis in MPP[Formula: see text] and MPTP-Induced Parkinson's Disease Models.
    Friedemann T; Ying Y; Wang W; Kramer ER; Schumacher U; Fei J; Schröder S
    Am J Chin Med; 2016; 44(5):907-25. PubMed ID: 27430912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective attributes of L-theanine, a bioactive amino acid of tea, and its potential role in Parkinson's disease therapeutics.
    Deb S; Dutta A; Phukan BC; Manivasagam T; Justin Thenmozhi A; Bhattacharya P; Paul R; Borah A
    Neurochem Int; 2019 Oct; 129():104478. PubMed ID: 31145971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.